Journal of Diabetes

Papers
(The H4-Index of Journal of Diabetes is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Factors leading to high morbidity and mortality of COVID‐19 in patients with type 2 diabetes109
COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?104
Diabetes and COVID‐1996
Diabetes mellitus association with coronavirus disease 2019 (COVID‐19) severity and mortality: A pooled analysis53
Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID‐19: Data from a multi‐site surveillance registry37
Care for diabetes with COVID‐19: Advice from China30
Determinants of mental health outcomes among people with and without diabetes during the COVID‐19 outbreak in the Arab Gulf Region27
A comparison of the stress hyperglycemia ratio, glycemic gap, and glucose to assess the impact of stress‐induced hyperglycemia on ischemic stroke outcome26
Measuring the global, regional, and national burden of type 2 diabetes and the attributable risk factors in all 194 countries25
Does inpatient hyperglycemia predict a worse outcome in COVID‐19 intensive care unit patients?25
Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review and meta‐analysis25
Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis24
Clinical characteristics and outcomes of COVID‐19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)24
Metabolic syndrome and clinical outcomes in patients infected with COVID‐19: Does age, sex, and race of the patient with metabolic syndrome matter?24
Diabetic ketoacidosis drives COVID‐19 related hospitalizations in children with type 1 diabetes23
Targeting the PI3K/Akt signaling pathway in pancreatic β‐cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes23
Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers23
The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID‐1922
New‐onset diabetes in “long COVID”20
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID‐19 pandemic20
0.097097873687744